Patent details
EP2506881 Title: COMBINING RADIOIMMUNOTHERAPY AND ANTIBODY-DRUG CONJUGATES FOR IMPROVED CANCER THERAPY
Basic Information
- Publication number:
- EP2506881
- PCT Application Number:
- US2010058519
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP108350364
- PCT Publication Number:
- WO2011068845
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINING RADIOIMMUNOTHERAPY AND ANTIBODY-DRUG CONJUGATES FOR IMPROVED CANCER THERAPY
- French Title of Invention:
- COMBINAISON DE RADIOIMMUNOTHERAPIE ET CONJUGUES ANTICORPS-MEDICAMENT POUR UNE MEILLEURE THERAPIE DU CANCER
- German Title of Invention:
- KOMBINATION AUS RADIOIMMUNTHERAPIE UND ANTIKÖRPER-ARZNEI-KONJUGATEN FÜR VERBESSERTE KREBSTHERAPIE
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 05/04/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 12/04/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 06/03/2024
- Unitary Effect Registration Date:
- 12/04/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 01/12/2010
- Grant date:
- 06/03/2024
- EP Publication Date:
- 10/10/2012
- PCT Publication Date:
- 09/06/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 06/03/2024
- EP B1 Publication Date:
- 06/03/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 01/12/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/02/2024
- Name:
- Immunomedics, Inc.
- Address:
- 300 American Road, Morris Plains, NJ 07950, United States (US)
Inventor
1
- Name:
- GOVINDAN, Serengulam V.
- Address:
- United States (US)
2
- Name:
- GOLDENBERG, David M.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 629404
- Priority Date:
- 02/12/2009
- Priority Country:
- United States (US)
2
- Priority Number:
- 266356 P
- Priority Date:
- 03/12/2009
- Priority Country:
- United States (US)
3
- Priority Number:
- 292656 P
- Priority Date:
- 06/01/2010
- Priority Country:
- United States (US)
4
- Priority Number:
- 322997 P
- Priority Date:
- 12/04/2010
- Priority Country:
- United States (US)
5
- Priority Number:
- 323952 P
- Priority Date:
- 14/04/2010
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 51/00; A61K 31/7068; A61K 51/10; A61K 41/00; A61K 39/00; A61K 47/68; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202410
- Publication date:
- 06/03/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202420
- Publication date:
- 15/05/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202420
- Publication date:
- 15/05/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|